Abstract
The Psychobiological Model of Temperament and Character (also known as the Seven Factor model) is described in detail in this review, in terms of its neurophysiological underpinnings, psychometric properties, and clinical applications in the diagnosis and treatment planning of personality disorder (PD). The Temperament and Character Inventory (TCI), a self-report test developed to assess temperament and character traits, is used to evaluate bio-genetic (temperament) and adaptive (character) aspects of personality. Diagnosis of PD is a 2-step process that involves both character assessment (character is essential to assess mal-adaptation, as the core impairment shared by all subtypes of PD) and temperament assessment (temperament is used to distinguish specific symptomatic presentations in differential diagnosis of PD). We advocate that the Seven Factor Model of Temperament and Character provides a theoretical framework for more productive research, assessment, and treatment of normal personality and PD. In addition, pharmacotherapy and psychotherapy of PD are discussed in some detail, including pharmacological management of temperament and psychotherapy of character based on TCI scores. Finally, congruence between the Seven Factor model and the expected DSM-5 classification of and approach to PD are discussed in some detail.
Keywords: Personality, personality disorder, pharmacotherapy, diagnosis, temperament, character, DSM-5, Psychobiological, Dysregulation, diagnosing maladaptation, narcissistic, egosyntonic, agoraphobia, paranoid, vascular dementia
Current Psychopharmacology
Title: Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Volume: 1
Author(s): Dragan M. Svrakic and C. Robert Cloninger
Affiliation:
Keywords: Personality, personality disorder, pharmacotherapy, diagnosis, temperament, character, DSM-5, Psychobiological, Dysregulation, diagnosing maladaptation, narcissistic, egosyntonic, agoraphobia, paranoid, vascular dementia
Abstract: The Psychobiological Model of Temperament and Character (also known as the Seven Factor model) is described in detail in this review, in terms of its neurophysiological underpinnings, psychometric properties, and clinical applications in the diagnosis and treatment planning of personality disorder (PD). The Temperament and Character Inventory (TCI), a self-report test developed to assess temperament and character traits, is used to evaluate bio-genetic (temperament) and adaptive (character) aspects of personality. Diagnosis of PD is a 2-step process that involves both character assessment (character is essential to assess mal-adaptation, as the core impairment shared by all subtypes of PD) and temperament assessment (temperament is used to distinguish specific symptomatic presentations in differential diagnosis of PD). We advocate that the Seven Factor Model of Temperament and Character provides a theoretical framework for more productive research, assessment, and treatment of normal personality and PD. In addition, pharmacotherapy and psychotherapy of PD are discussed in some detail, including pharmacological management of temperament and psychotherapy of character based on TCI scores. Finally, congruence between the Seven Factor model and the expected DSM-5 classification of and approach to PD are discussed in some detail.
Export Options
About this article
Cite this article as:
M. Svrakic Dragan and Robert Cloninger C., Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020122
DOI https://dx.doi.org/10.2174/2211556011201020122 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Biology of the RNA Binding Protein Guanine-Rich Sequence Binding Factor 1
Current Protein & Peptide Science Conantokins: Peptide Antagonists of NMDA Receptors
Current Medicinal Chemistry Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
Recent Patents on Anti-Cancer Drug Discovery High-Level Expression and Purification of an Analgesic Peptide from Buthus martensii Karch
Protein & Peptide Letters Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets High Temperature Unfolding Simulations of a Single-stranded DNA i-Motif
Current Physical Chemistry Voltage-Gated Sodium Channel Blockers as Immunomodulators
Recent Patents on CNS Drug Discovery (Discontinued) Histone Deacetylase Inhibitors in Psoriasis Therapy
Current Drug Targets - Inflammation & Allergy Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Sulfur – Containing Amino Acids in Seizures: Current State of the Art
Current Medicinal Chemistry Rational Drug Development Using Gene-Targeted Agents and Their Application in Anti-Gene Radiotherapy
Current Genomics Regulation of Medical Devices and their Clinical Trials Studies in the USA: An Update
Recent Innovations in Chemical Engineering Filtering Disturbances in Schizophrenic Patients. Gating of Auditory Evoked Potentials and Prepulse Inhibition of the Acoustic Startle Response Compared. Emphasis on the Role of Dopamine
Current Neuropharmacology Recent Progress in Transition-Metal-Catalyzed C-N Cross-Couplings: Emerging Approaches Towards Sustainability
Current Organic Synthesis Aliphatic and Aromatic Oxidations, Epoxidation and S-Oxidation of Prodrugs that Yield Active Drug Metabolites
Current Medicinal Chemistry Calcium Channels and Prostate Cancer
Recent Patents on Anti-Cancer Drug Discovery Anti-Carcinogenic Effects of Carnosol-An Updated Review
Current Drug Discovery Technologies Biomedical Applications of Nanomaterials as Therapeutics
Current Medicinal Chemistry Design, Synthesis and Protection Against Pentylenetetrazole-induced Seizure of N-aryl Derivatives of the Phthalimide Pharmacophore
Medicinal Chemistry Current κ Opioid Receptor Ligands and Discovery of a New Molecular Scaffold as a κ Opioid Receptor Antagonist Using Pharmacophore-Based Virtual Screening
Current Pharmaceutical Design